The article says few randomized controlled trials compare that pairing directly against monotherapy or placebo, and that providers considering it rely on mechanistic reasoning, patient phenotypes, and real-world experience rather than large-scale trial data
individuals with a history of medullary thyroid cancer, multiple endocrine neoplasia syndrome type 2, pancreatitis, or severe gastrointestinal conditions should consult their provider about other alternatives
But it does require physician monitoring and is contraindicated in certain conditions including active cancer
A 2025 study in Diabetes, Obesity, and Metabolism found that participants reported improvements in food-related thoughts, feelings of fullness, and overall healthier eating behaviors
"After more than a decade of progress in body positivity, were witnessing the resurgence of an impossible standard one that pressures people of all shapes and sizes to shrink themselves at any cost," Amron continued
Utilizing both the GLP-1 and GIP receptors, Tirzepatide can therefore bring greater better metabolic benefits